A phase 1/2A open-label study of pralatrexate and gemcitabine in patients with relapsed or refractory lympboprolifierative malignancies Meeting Abstract


Authors: Horwitz, S. M.; Vose, J. M.; Advani, R.; Sankhala, K.; Padmanabhan, S.; Hamlin, P. A.; Chen, A.; Wilroy, S.; Zain, J. M.; Wright, D.; Weissbrot, H.; Hohenstein, M.; Cagnoni, P. J.; Saunders, M. E.; O'Connor, O. A.
Abstract Title: A phase 1/2A open-label study of pralatrexate and gemcitabine in patients with relapsed or refractory lympboprolifierative malignancies
Meeting Title: 50th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 112
Issue: 11
Meeting Dates: 2008 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2008-11-16
Start Page: 557
Language: English
ACCESSION: WOS:000262104701791
PROVIDER: wos
PUBMED: 22276298
DOI: 10.1182/blood.V112.11.1570.1570
Notes: --- - Meeting Abstract: 1570 - Poster Session - 50th Annual Meeting of the American-Society-of-Hematology - DEC 06-09, 2008 - San Francisco, CA - "Source: Wos"
Altmetric
Citation Impact
MSK Authors
  1. Steven M Horwitz
    595 Horwitz
  2. Paul Hamlin
    257 Hamlin